5-Methoxy-6-(4-methyl-piperazin-1-yl)-2,3-dihydro-indole-1-carboxylic acid (2,3-dichloro-phenyl)-amide

ID: ALA195432

Chembl Id: CHEMBL195432

PubChem CID: 44402870

Max Phase: Preclinical

Molecular Formula: C21H24Cl2N4O2

Molecular Weight: 435.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2c(cc1N1CCN(C)CC1)N(C(=O)Nc1cccc(Cl)c1Cl)CC2

Standard InChI:  InChI=1S/C21H24Cl2N4O2/c1-25-8-10-26(11-9-25)18-13-17-14(12-19(18)29-2)6-7-27(17)21(28)24-16-5-3-4-15(22)20(16)23/h3-5,12-13H,6-11H2,1-2H3,(H,24,28)

Standard InChI Key:  DJTDQOVOQOPRSJ-UHFFFAOYSA-N

Associated Targets(Human)

HTR1A Tclin Serotonin 1a (5-HT1a) receptor (14969 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1B Tclin Serotonin 1b (5-HT1b) receptor (2801 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1D Tclin Serotonin 1d (5-HT1d) receptor (2897 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HTR1B Tclin Serotonin 1 receptors; 5-HT1B & 5-HT1D (345 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 435.36Molecular Weight (Monoisotopic): 434.1276AlogP: 4.35#Rotatable Bonds: 3
Polar Surface Area: 48.05Molecular Species: NEUTRALHBA: 4HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 10.72CX Basic pKa: 7.40CX LogP: 4.03CX LogD: 3.73
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.78Np Likeness Score: -1.66

References

1. Wyman PA, Marshall HR, Flynn ST, King RJ, Thompson M, Smith PW, Hadley MS, Price GW, Scott CM, Dawson LA..  (2005)  Identification of a potent and selective 5-HT1B receptor antagonist.,  15  (21): [PMID:16153839] [10.1016/j.bmcl.2005.07.085]

Source